Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Arthritis Research and Therapy

Volumn 11, Issue 1, 2009, Pages

  Hanke, Katharina ^a   Brückner, Claudia S ^a   Dähnrich, Cornelia ^b   Huscher, Dörte ^a   Komorowski, Lars ^b   Meyer, Wolfgang ^b   Janssen, Anthonia ^b   Backhaus, Marina ^a   Becker, Mike ^a   Kill, Angela ^a   Egerer, Karl ^a   Burmester, Gerd R ^a   Hiepe, Falk ^a   Schlumberger, Wolfgang ^b   Riemekasten, Gabriela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Experimental Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MOLECULAR MARKER; NUCLEOSOME AUTOANTIBODY; PM SCL 100 ANTIBODY; PM SCL 75 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; POLYMYOSISTIS SCLERODERMA ANTIGEN, HUMAN; POLYMYOSISTIS-SCLERODERMA ANTIGEN, HUMAN;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOBLOTTING; LABORATORY TEST; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; POLYMYOSITIS; PREVALENCE; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; BLOOD; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; HUMANS; IMMUNOBLOTTING; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 61649098168     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2614     Document Type: Article

References (31)

1. Reichlin M Maddison PJ Targoff I Bunch T Arnett F Sharp G Treadwell E Tan EM Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes J Clin Immunol 1984, 4:40-44 10.1007/ BF00915286 6699138
2. Steen VD Autoantibodies in systemic sclerosis Semin Arthritis Rheum 2005, 35:35-42 10.1016/j.semarthrit.2005.03.005 16084222
3. Mahler M Raijmakers R Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights Autoimmun Rev 2007, 6:432-437 10.1016/j.autrev.2007.01.013 17643929
4. Oddis CV Okano Y Rudert WA Trucco M Duquesnoy RJ Medsger TA Jr Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations Arthritis Rheum 1992, 35:1211-1217 10.1002/art.1780351014 1418007
5. Marguerie C Bunn CC Copier J Bernstein RM Gilroy JM Black CM So AK Walport MJ The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl Medicine (Baltimore) 1992, 71:327-336 10.1097/00005792-199211000-00001 1435228
6. Vandergheynst F Ocmant A Sordet C Humbel RL Goetz J Roufosse F Cogan E Sibilia J Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients Clin Exp Rheumatol 2006, 24:129-133 16762146
7. Alderuccio F Chan EK Tan EM Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex J Exp Med 1991, 173:941-952 2190817 2007859 10.1084/ jem.173.4.941
8. Blüthner M Bautz FA Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein J Exp Med 1992, 176:973-980 2119404 1383382 10.1084/jem.176.4.973
9. Raijmakers R Renz M Wiemann C Egberts WV Seelig HP van Venrooij WJ Pruijn GJ PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome Arthritis Rheum 2004, 50:565-569 10.1002/art.20056 14872500
10. Raijmakers R Egberts WV van Venrooij WJ Pruijn GJ The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus J Biol Chem 2003, 278:30698-30704 10.1074/ jbc.M302488200 12788944
11. Mahler M Raijmakers R Dähnrich C Blüthner M Fritzler MJ Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen Arthritis Res Ther 2005, 7:R704-713 1174964 15899056 10.1186/ar1729
12. Hanke K Dahnrich C Bruckner C Huscher D Becker M Janssen A Meyer W Egerer K Hiepe F Burmester G R Schlumberger W Riemekasten G Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort Arthritis Res Ther 2009, 11:R28 19232127 10.1186/ar2622
13. Walker UA Tyndall A Czirják L Denton C Farge-Bancel D Kowal-Bielecka O Müller-Ladner U Bocelli-Tyndall C Matucci-Cerinic M Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials And Research group database Ann Rheum Dis 2007, 66:754-763 10.1136/ard.2006.062901 17234652
14. Hunzelmann N Genth E Krieg T Lehmacher W Melchers I Meurer M Moinzadeh P Müller-Ladner U Pfeiffer C Riemekasten G Schulze-Lohoff E Sunderkoetter C Weber M Worm M Klaus P Rubbert A Steinbrink K Grundt B Hein R Scharffetter-Kochanek K Hinrichs R Walker K Szeimies RM Karrer S Müller A Seitz C Schmidt E Lehmann P Foeldvári I Reichenberger F Registry of the German Network for Systemic Scleroderma. The registry of the German Network for Systemic Scleroderma: Frequency of disease subsets and patterns of organ involvement Rheumatology (Oxford) 2008, 47:1185-1192 2468885 18515867 10.1093/rheumatology/ken179
15. Czirják L Nagy Z Aringer M Riemekasten G Matucci-Cerinic M Furst DE EUSTAR The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis Ann Rheum Dis 2007, 66:966-969 10.1136/ard.2006.066530 17234649
16. LeRoy EC Black C Fleischmajer R Jablonska S Krieg T Medsger TA Jr Rowell N Wollheim F Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis J Rheumatol 1988, 15:202-205 3361530
17. Bennett RM Scleroderma overlap syndrome Rheum Dis Clin North Am 1990, 16:185-198 2406807
18. Rodnan GP Fennel RH Jr Progressive systemic sclerosis sine scleroderma JAMA 1962, 180:665-670 14493142
19. Mosca M Neri R Bombardieri S Undifferentiated connective tissue diseases (UCTD): A review of the literature and a proposal for preliminary classification criteria Clin Exp Rheumatol 1999, 17:615-620 10544849
20. Vitali C Bombardieri S Moutsopoulos HM Balestrieri G Bencivelli W Bernstein RM Bjerrum KB Braga S Coll J de Vita S Drosos AA Ehrenfeld M Hatron PY Hay EM Isenberg DA Janin A Kalden JR Kater L Konttinen YT Maddison PJ Maini RN Manthorpe R Meyer O Ostuni P Pennec Y Prause JU Richards A Sauvezie B Schiødt M Sciuto M et al.: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community Arthritis Rheum 1993, 36:340-347 10.1002/art.1780360309 8452579
21. Tan EM Cohen AS Fries JF Masi AT McShane DJ Rothfield NF Schaller JG Talal N Winchester RJ The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982, 25:1271-1277 10.1002/art.1780251101 7138600
22. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS Medsger TA Jr Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324 10.1002/ art.1780310302 3358796
23. Furst DE Clements PJ Steen VD Medsger TA Jr Masi AT D'Angelo WA Lachenbruch PA Grau RG Seibold JR The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis J Rheumatol 1998, 25:84-88 9458208
24. Valentini G Bencivelli W Bombardieri S D'Angelo S Della Rossa A Silman AJ Black CM Czirjak L Nielsen H Vlachoyiannopoulos PG European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria Ann Rheum Dis 2003, 62:901-903 1754649 12922968 10.1136/ard.62.9.901
25. Blüthner M Mahler M Müller DB Dünzl H Bautz FA Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides J Mol Med 2000, 78:47-54 10.1007/s001090050381 10759029
26. Selva-O'Callaghan A Labrador-Horrillo M Solans-Laque R Simeon-Aznar CP Martínez-Gómez X Vilardell-Tarrés M Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy Arthritis Rheum 2006, 55:791-798 10.1002/art.22237 17013837
27. Brouwer R Vree Egberts WT Hengstman GJ Raijmakers R van Engelen BG Seelig HP Renz M Mierau R Genth E Pruijn GJ van Venrooij WJ Autoantibodies directed to novel components of the PM/Scl complex, the human exosome Arthritis Res 2002, 4:134-138 83843 11879549 10.1186/ar389
28. Brouwer R Hengstman GJ Vree Egberts W Ehrfeld H Bozic B Ghirardello A Grøndal G Hietarinta M Isenberg D Kalden JR Lundberg I Moutsopoulos H Roux-Lombard P Vencovsky J Wikman A Seelig HP van Engelen BG van Venrooij WJ Autoantibody profiles in the sera of European patients with myositis Ann Rheum Dis 2001, 60:116-123 1753477 11156543 10.1136/ard.60.2.116
29. Mahler M Mierau R Humbel RL Fritzler MJ Anti-PM1-alpha antibodies: analytical evaluation in two centers Paper presented at: 6th International Congress on Autoimmunity; 10-14 September 2008; Porto, Portugal
30. Schmidt M Hoffman DR Expression systems for production of recombinant allergens Int Arch Allergy Immunol 2002, 128:264-270 10.1159/000063865 12218364
31. Hu YC Baculovirus as a highly efficient expression vector in insect and mammalian cells Acta Pharmacol Sin 2005, 26:405-416 Review 10.1111/ j.1745-7254.2005.00078.x 15780188